Motley Bio is a tech bio company redefining how biological systems are measured, modeled, and translated into actionable insight.  We create a novel class of multidimensional biological data purpose-built for drug discovery and molecular diagnostics.

We enable clinical insights that are not achievable with traditional "omic" approaches.

Motley Bio provides a unified, high-resolution view of biology optimized for AI-driven target discovery, biomarker development, adaptive clinical trials, early disease detection, and multimodal model training to drive clinical insights.